In September, the company officially relocated its headquarters from a 114,000-square-foot space in New York City to a ...

Executives from Impact Analytics and Carters Inc. discuss demographic shifts, changing compositions, weight loss drugs and ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

an annual meeting highlighting progress in the weight loss arena. For example, during the event, AstraZeneca shared promising ...

There's a new player in the running game, and it's not the latest carbon-plated shoe or fancy GPS watch. GLP-1 medications ...

Analyzing H&H's Q3 results and investment strategy in the healthcare industry, highlighting undervaluation and raising the ...

According to the American Association of Nurse Practitioners, there are more than 385,000 nurse practitioners (NPs) licensed in the United States. NPs ...

Susan McGowan, 58, died in September after taking two doses of the new generation of weight loss jabs known as GLP-1 agonists ...

Losing weight on GLP-1 drugs like Ozempic isn't guaranteed. Experts reveal how to tell if yours isn't working and the next steps you should take to reach your weight loss goals.

Use of the weight loss drug was also linked to shorter hospital stays. Eli Lilly and Novo Nordisk are the main players in the GLP-1 field, but they're facing competition from compounding pharmacies, ...